F. Edmondson
General Counsel en ZAI LAB LIMITED .
Fortuna: 446 847 $ al 31/03/2024
Perfil
F.
Ty Edmondson is currently the Chief Legal Officer at Zai Lab Ltd.
Prior to this role, he held positions at Sumitomo Pharma America, Inc. as Secretary, Associate General Counsel & VP, and at Biogen, Inc. as Chief Corporation Counsel & Senior Vice President.
He completed his undergraduate degree at Washington & Lee University in 1988 and his graduate degree at Widener University School of Law in 1993.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZAI LAB LTD.
0.03% | 04/04/2024 | 271 102 ( 0.03% ) | 446 847 $ | 31/03/2024 |
Cargos activos de F. Edmondson
| Empresas | Cargo | Inicio |
|---|---|---|
| ZAI LAB LIMITED | General Counsel | 07/08/2020 |
Antiguos cargos conocidos de F. Edmondson.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/08/2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Secretary | - |
Formación de F. Edmondson.
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Bolsa de valores
- Insiders
- F. Edmondson
